<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css"> Skip to main content

EGFR Tyrosine Kinase Inhibitor-Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic

dc.citation.epage0en_US
dc.citation.issue8en_US
dc.citation.spage0en_US
dc.citation.volume15en_US
dc.citation.woscount0en_US
dc.contributor.authorChang, Hsu-Liangen_US
dc.contributor.authorChen, Yen-Hsuen_US
dc.contributor.authorTaiwan, Hsin-Chuen_US
dc.contributor.authorYang, Chih-Jenen_US
dc.contributor.department生醫工程研究所zh_TW
dc.contributor.departmentInstitute of Biomedical Engineeringen_US
dc.date.accessioned2020-10-05T02:01:09Z
dc.date.available2020-10-05T02:01:09Z
dc.date.issued2020-08-01en_US
dc.identifier.doi10.1016/j.jtho.2020.04.029en_US
dc.identifier.issn1556-0864en_US
dc.identifier.journalJOURNAL OF THORACIC ONCOLOGYen_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.jtho.2020.04.029en_US
dc.identifier.urihttps://ir.lib.nycu.edu.tw/handle/11536/155185
dc.identifier.wosnumberWOS:000552738300001en_US
dc.language.isoen_USen_US
dc.titleEGFR Tyrosine Kinase Inhibitor-Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemicen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: